Literature DB >> 32964277

Clinical and pathological characteristics of ANA/anti-dsDNA positive patients with antineutrophil cytoplasmic autoantibody-associated vasculitis.

Xiaohong Zhao1,2, Qiong Wen1, Yagui Qiu1, Fengxian Huang3.   

Abstract

Antineutrophil cytoplasmic autoantibodies (ANCA) associated vasculitis (AAV) consists of a group of systemic autoimmune diseases. The roles of serum anti-nuclear antibodies (ANA) and anti-double-stranded DNA (anti-dsDNA) antibodies in AAV patients remain unknown. This study investigated the prevalence of serum ANAs and anti-dsDNA antibodies in AAV patients and characterized the clinical and pathological features of these patients. A total of 218 AAV patients were enrolled. Clinical and pathological data of patients were analyzed retrospectively. Of the 218 AAV patients, 109 (50.0%) were positive for ANA, 45 (20.6%) were positive for anti-dsDNA, and 43 (19.7%) were positive for both. The AAV patients with ANA had severer kidney damage and more chronic renal histopathological changes compared to those who were negative for ANA. Specifically, patients positive for ANA had more hypertension, higher levels of urea nitrogen and serum creatinine, lower estimated glomerular filtration rate (eGFR), more end-stage renal disease (ESRD), severer proteinuria, glomerular sclerosis, tubular interstitial fibrosis and tubular atrophy, and were more likely to receive renal biopsies compared to ANA negative patients. The study found ANA and anti-dsDNA in AVV patients were not rare, ANA-positive AAV patients had severer kidney damage and more chronic renal histopathological changes compared to ANA-negative AAV patients. Renal biopsy is strongly recommended for differential diagnosis in such cases.

Entities:  

Keywords:  Anti-double stranded DNA antibodies (anti-dsDNA); Anti-nuclear antibody (ANA); Antineutrophil cytoplasmic autoantibodies (ANCA); Associated vasculitis (AAV); Clinicopathological characteristics

Year:  2020        PMID: 32964277      PMCID: PMC7835286          DOI: 10.1007/s00296-020-04704-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  15 in total

1.  ANA, DNA, and SLE.

Authors:  J L Pinnas; P E Fenster
Journal:  Ariz Med       Date:  1977-04

2.  Clinical [corrected] and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre.

Authors:  M Chen; F Yu; Y Zhang; M H Zhao
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

3.  Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.

Authors:  J A Savige; L Chang; D Wilson; R R Buchanan
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

Review 4.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

5.  Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.

Authors:  Feng Yu; Min Chen; Su-Xia Wang; Wan-Zhong Zou; Ming-Hui Zhao; Hai-Yan Wang
Journal:  Nephrology (Carlton)       Date:  2007-02       Impact factor: 2.506

Review 6.  ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review.

Authors:  Petar Lenert; Michael Icardi; Laila Dahmoush
Journal:  Clin Rheumatol       Date:  2013-04-21       Impact factor: 2.980

Review 7.  Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks.

Authors:  O P Rekvig
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

8.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

9.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

10.  2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

Authors:  Martin Aringer; Karen Costenbader; David Daikh; Ralph Brinks; Marta Mosca; Rosalind Ramsey-Goldman; Josef S Smolen; David Wofsy; Dimitrios T Boumpas; Diane L Kamen; David Jayne; Ricard Cervera; Nathalie Costedoat-Chalumeau; Betty Diamond; Dafna D Gladman; Bevra Hahn; Falk Hiepe; Søren Jacobsen; Dinesh Khanna; Kirsten Lerstrøm; Elena Massarotti; Joseph McCune; Guillermo Ruiz-Irastorza; Jorge Sanchez-Guerrero; Matthias Schneider; Murray Urowitz; George Bertsias; Bimba F Hoyer; Nicolai Leuchten; Chiara Tani; Sara K Tedeschi; Zahi Touma; Gabriela Schmajuk; Branimir Anic; Florence Assan; Tak Mao Chan; Ann Elaine Clarke; Mary K Crow; László Czirják; Andrea Doria; Winfried Graninger; Bernadett Halda-Kiss; Sarfaraz Hasni; Peter M Izmirly; Michelle Jung; Gábor Kumánovics; Xavier Mariette; Ivan Padjen; José M Pego-Reigosa; Juanita Romero-Diaz; Íñigo Rúa-Figueroa Fernández; Raphaèle Seror; Georg H Stummvoll; Yoshiya Tanaka; Maria G Tektonidou; Carlos Vasconcelos; Edward M Vital; Daniel J Wallace; Sule Yavuz; Pier Luigi Meroni; Marvin J Fritzler; Ray Naden; Thomas Dörner; Sindhu R Johnson
Journal:  Arthritis Rheumatol       Date:  2019-08-06       Impact factor: 15.483

View more
  2 in total

1.  Long-Term Prognostic Factors in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A 15-Year Multicenter Retrospective Study.

Authors:  Qian-Qian Liao; Ya-Fei Ren; Ke-Wei Zhu; Dong Qin; Yan-Ju Mo; Shan Cong; Juan Wu; Chun-Ying Wang; Xiao-Jiao Cui; Hong-Zhen Xu; Lin-Zheng Guo; You-Yan Zhang; Hai-Xia Song; Wei Zhang; Zhe Yang; Yan-Feng Tang; Zhuo-Jun Li; Zhou-Ni Xie; Li-Mei Li; Hui-Juan Wang; Meng-Meng Zhou; Fang-Ning Wei; Peng Chen; Yu-Hong Shi
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 2.  Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature.

Authors:  Inge C Van Gool; Jesper Kers; Jaap A Bakker; Joris I Rotmans; Y K Onno Teng; Martijn P Bauer
Journal:  Clin Rheumatol       Date:  2022-06-23       Impact factor: 3.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.